Healthcare Industry News: Magnetic Resonance Imaging
News Release - April 15, 2008
TeraRecon Founds German Subsidiary and Establishes European HeadquartersSAN MATEO, CA--(Healthcare Sales & Marketing Network)--Apr 15, 2008 -- TeraRecon, Inc. (www.terarecon.com), a leader in advanced image processing technology and 3D visualization solutions for medical imaging applications, today announced the formation of TeraRecon GmbH, registered in Frankfurt, Germany, a wholly owned subsidiary of TeraRecon, Inc., and the new European headquarters for TeraRecon.
"As TeraRecon's European operations have grown dramatically over recent years, the time has come to establish a European headquarters to provide a center of business operations for this extremely important market in the global context," said Robert Taylor, Ph.D., TeraRecon president and chief operating officer. "TeraRecon is now supporting operations in over 15 European countries with sales, marketing, clinical and technical support staff throughout the region. To accommodate this ever-increasing scale of operations, we determined that Frankfurt, centrally located in the EU and well-equipped for rapid response to anywhere in the region, would be the optimum location for our European headquarters and we are very pleased to announce the formation of TeraRecon GmbH with this goal in mind. TeraRecon already enjoys substantial market share in the US and Japanese markets, and we are committed to further developing our business to realize its full potential in Europe, now that we have several years of experience in the diverse and exiting European community, and many friends and colleagues here who have helped to define and shape our solutions over the years."
TeraRecon's flagship product line, Aquarius iNtuition, is an enterprise-class system for advanced 3D visualization of medical imaging examinations obtained by Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scanners, among other medical imaging modalities.
Aquarius iNtuition provides real-time 3D visualization and a comprehensive suite of decision support tools that are integrated into the imaging workflow to speed diagnostic interpretation and enrich the imaging experience with additional information that would not otherwise be available. Automated and intelligent pre-processing engines identify and label scans and perform "zero-click" procedures in advance of human interaction with the data. Streamlined and tailored Workflow Templates, specifying a sequence of interpretation steps, are provided to speed the process of 3D navigation through the dataset so that the physician may focus their time and concentration on the interpretation process itself.
About TeraRecon, Inc. and TeraRecon GmbH (www.terarecon.com)
TeraRecon GmbH, located in Frankfurt, Germany is a wholly owned subsidiary of TeraRecon, Inc. and the primary corporate entity for TeraRecon's European operations. TeraRecon Inc., a leader in advanced image processing and 3D visualization techniques, provides advanced imaging systems for medical and other visualization applications based on its unique and patented image processing technologies. A four-time winner of Frost and Sullivan awards and selected by the US consumer research company KLAS as the top 3D vendor in the 2007 mid-year survey, the company has developed a leading portfolio of products that advance the performance, quality, functionality, and integration of image processing and 3D visualization systems. Founded in 1997, TeraRecon has developed a unique family of powerful processors that are used in its real-time, enterprise-wide image processing solutions and real-time 3D volume rendering hardware engines. TeraRecon is a fast growing, privately held company with over 2,800 installations globally with headquarters in San Mateo, California, USA, and branch offices in Concord, Massachusetts, USA; Tokyo, Japan; Osaka, Japan; and its European subsidiary, TeraRecon GmbH in Frankfurt, Germany.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.